Inventor
OKUHARA MASAKUNI
JP41 patents
⚠️ This page may combine multiple inventors who share the name “OKUHARA MASAKUNI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
39 patentsUS4894366AJan 16, 1990
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO214 citations99
US4929611AMay 29, 1990
Method for immunosuppression
FUJISAWA PHARMACEUTICAL CO105 citations97
US5624842AApr 29, 1997
Strain of Streptomyces for the production of tricyclo compounds
FUJISAWA PHARMACEUTICAL CO35 citations96
US5496727AMar 5, 1996
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO22 citations96
US4956352ASep 11, 1990
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO48 citations96
US5376634ADec 27, 1994
Polypeptide compound and a process for preparation thereof
FUJISAWA PHARMACEUTICAL CO57 citations95
US4977138ADec 11, 1990
FR901228 substance and preparation thereof
FUJISAWA PHARMACEUTICAL CO92 citations95
US5254562AOct 19, 1993
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO25 citations92
US5187195AFeb 16, 1993
Anthraquinone derivatives and preparation thereof
FUJISAWA PHARMACEUTICAL CO45 citations90
US6028097AFeb 22, 2000
Method of immunosuppression
FUJISAWA PHARMACEUTICAL CO8 citations82
US5830717ANov 3, 1998
Process for production of tricyclo compounds with streptomyces
FUJISAWA PHARMACEUTICAL CO9 citations82
US5565559AOct 15, 1996
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO8 citations82
US5110811AMay 5, 1992
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO20 citations82
US5037809AAug 6, 1991
Antimicrobial agent, FR109615 and production thereof
FUJISAWA PHARMACEUTICAL CO15 citations80
US6482845B1Nov 19, 2002
Method for inhibiting interleukin-2 production using tricyclo compounds
FUJISAWA PHARMACEUTICAL CO2 citations74
US6201005B1Mar 13, 2001
Method for inhibiting lymphokine production
FUJISAWA PHARMACEUTICAL CO5 citations74
US5266692ANov 30, 1993
Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO12 citations74
US6110933AAug 29, 2000
Amino acid derivatives and their use as phospholipase A2 inhibitor
FUJISAWA PHARMACEUTICAL CO9 citations73
US5447854ASep 5, 1995
Production of cyclosporin A and/or C with a strain of NECTRIA
FUJISAWA PHARMACEUTICAL CO7 citations73
US5502033AMar 26, 1996
Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
FUJISAWA PHARMACEUTICAL CO10 citations72
US5061730AOct 29, 1991
Carboxylic acid derivatives
FUJISAWA PHARMACEUTICAL CO6 citations72
US5545542AAug 13, 1996
WB2663 substances and method for their production
FUJISAWA PHARMACEUTICAL CO13 citations71
US5514715AMay 7, 1996
Antimicrobial agent, FR109615 and production thereof
FUJISAWA PHARMACEUTICAL CO8 citations71
US5279826AJan 18, 1994
Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
FUJISAWA PHARMACEUTICAL CO6 citations69
US5409701AApr 25, 1995
FR901451 substance, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations63
US5547934AAug 20, 1996
WF11243 substance
FUJISAWA PHARMACEUTICAL CO3 citations62
US5446022AAug 29, 1995
WF11243 substance
FUJISAWA PHARMACEUTICAL CO2 citations62
US5364624ANov 15, 1994
WS7622A mono- or di-sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5292510AMar 8, 1994
WS7622A mono- or di- sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5167958ADec 1, 1992
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use for treatment of pulmonary emphysema and adult respiratory distress syndrome
FUJISAWA PHARMACEUTICAL CO3 citations62
US5043354AAug 27, 1991
Pharmaceutically useful 5-hydroxy-2,3-dihydro-benzofurans and 5-hydroxy-benzofurans
FUJISAWA PHARMACEUTICAL CO5 citations62
US5021240AJun 4, 1991
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations62
US4143135AMar 6, 1979
Antibiotic phosphonic acid derivatives and production and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5436140AJul 25, 1995
Process for producing WS-9326A and WS-9326B
FUJISAWA PHARMACEUTICAL CO4 citations61
US4680178AJul 14, 1987
Antitumor agent comprising FR-900216
FUJISAWA PHARMACEUTICAL CO2 citations61
US5217952AJun 8, 1993
Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
FUJISAWA PHARMACEUTICAL CO2 citations51
US4963585AOct 16, 1990
Compound, WF11605 and derivative thereof
FUJISAWA PHARMACEUTICAL CO0 citations51
US4939241AJul 3, 1990
Amino acid derivatives of antitumor activity
FUJISAWA PHARMACEUTICAL CO1 citations51
US4910017AMar 20, 1990
New compounds WF 2015 A and B
FUJISAWA PHARMACEUTICAL CO0 citations40